Navigation Links
Brand new Solid Form Co-Crystals and Amorphous Focus Morning at the Pharmaceutical Co-Crystals and Amorphous Material 2012 Summits
Date:9/4/2012

LONDON, September 4, 2012 /PRNewswire/ --

Pharma IQ recently launched its 2012 Pharmaceutical Co-Crystals and Amorphous Materials Summit programmes, featuring a brand new Solid Form Co-Crystals and Amorphous Focus Morning. This Focus Morning is aim to discovery the overlapping and discuss crucial areas that are involved in both, as well as to give participants as much input and expertise from across both areas in one space.

The Solid Form Co-Crystals and Amorphous Focus Morning features case studies and interactive sessions on the effective characterisation of co-crystals and amorphous. From the discriminatory analysis on dissolution behaviour of several disordered/amorphous forms to amorphous fractions in crystalline materials. These topics will help participants to understand structure and dynamics in pharmaceutical solids.

Four professors from UK's leading labs will lead roundtable discussions which will cover pressing questions about the future application of co-crystals and amorphous techniques both in pharmaceuticals and outside, the latest developments affecting bioavailability and the FDA policy of solid form.

In addition to the Focus Morning, the 2012 summit programme will assess the clinical application of co-crystals and amorphous forms into the manufacturing scale up process, focus on developing and forming effective co-crystals and amorphous designs throughout the phases of development and utilise novel methods of formulation identification to improve drug efficacy, reduce cost of development and expedite time to market.

With the release of the new FDA draft guidance on classification of solid form and the regulatory implications of this classification, it is crucial to learn the newest and most innovative developments in characterisation, predictability, processing as well as the legal and regulatory challenges.

Taking place from 25th to 26th September, Pharmaceutical Co-Crystals and Am
'/>"/>

SOURCE Pharma IQ
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. PAZOO Prepares For First Three National Direct Response Campaigns and Distribution of PAZOO Branded Products
2. Kaiser Permanente Appoints Alexandra Morehouse as Vice President of Advertising and Brand Management
3. Optimal Radiology Unveils New Brand
4. Verify Brand Supports the Proposed FDA Unique Device Identification (UDI) System for Medical Devices
5. OTC Consumer Brand Loyalty Falters in Wake of Branded Recalls, Change in FSA Law, and Recession - Finds Kline
6. U.S. Physician Survey: Stents by Brand, Length, Diameter, Type and Coating 2012
7. Ancor and Merit acquire Uplift Technologies for Carex Health Brands
8. Education, Reimbursement Options are Key Components of Effective Pharmaceutical Brand Websites
9. Forbes Names Pharmalot, a UBM Canon Pharmaceutical Media Group Brand, as a Top Social Media Influencer
10. Lilly Expands Strategic Partnership with Chinese Manufacturer Novast to Serve Chinese Patients with High-Quality Branded Generic Medicines
11. Cannabis Science Gets Set to Release "Phytiva" Its Newest Brand of Over-the-Counter Skin and Nutraceutical Product Lines Through its Newest Venture Phytiva Pharmaceuticals Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... , N.Y. and MEXICO CITY , ... today announced that PLM, a Latin American healthcare sciences ... to deliver medical information on conditions such as cancer ... can now access the most up-to-date information to deliver ... medical professionals is growing rapidly, with many relying on ...
(Date:7/25/2014)... , July 25, 2014  AMETEK, Inc. (NYSE: ... Kurtis L. Goos as Vice President and General ... and Packaging (EMIP) Division. "I am pleased ... management and business development experience, especially in the medical ... contributions to the continued growth and success of our ...
(Date:7/25/2014)... NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR ... JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF ... ABBV ) today announced financial results for the ... was another very strong quarter for AbbVie, as we delivered ... announced plans to merge with Shire, a strategic action that ...
Breaking Medicine Technology:Healthcare Sciences Publisher PLM and IBM Speed Access to Medical Information to Deliver Better Patient Care with Mobile 2Healthcare Sciences Publisher PLM and IBM Speed Access to Medical Information to Deliver Better Patient Care with Mobile 3Healthcare Sciences Publisher PLM and IBM Speed Access to Medical Information to Deliver Better Patient Care with Mobile 4AMETEK Names Kurtis L. Goos, Vice President & General Manager, Engineered Medical Components 2AbbVie Reports Second-Quarter 2014 Financial Results 2AbbVie Reports Second-Quarter 2014 Financial Results 3AbbVie Reports Second-Quarter 2014 Financial Results 4AbbVie Reports Second-Quarter 2014 Financial Results 5AbbVie Reports Second-Quarter 2014 Financial Results 6AbbVie Reports Second-Quarter 2014 Financial Results 7AbbVie Reports Second-Quarter 2014 Financial Results 8AbbVie Reports Second-Quarter 2014 Financial Results 9AbbVie Reports Second-Quarter 2014 Financial Results 10AbbVie Reports Second-Quarter 2014 Financial Results 11AbbVie Reports Second-Quarter 2014 Financial Results 12AbbVie Reports Second-Quarter 2014 Financial Results 13AbbVie Reports Second-Quarter 2014 Financial Results 14AbbVie Reports Second-Quarter 2014 Financial Results 15AbbVie Reports Second-Quarter 2014 Financial Results 16AbbVie Reports Second-Quarter 2014 Financial Results 17AbbVie Reports Second-Quarter 2014 Financial Results 18AbbVie Reports Second-Quarter 2014 Financial Results 19AbbVie Reports Second-Quarter 2014 Financial Results 20AbbVie Reports Second-Quarter 2014 Financial Results 21AbbVie Reports Second-Quarter 2014 Financial Results 22AbbVie Reports Second-Quarter 2014 Financial Results 23AbbVie Reports Second-Quarter 2014 Financial Results 24AbbVie Reports Second-Quarter 2014 Financial Results 25AbbVie Reports Second-Quarter 2014 Financial Results 26AbbVie Reports Second-Quarter 2014 Financial Results 27AbbVie Reports Second-Quarter 2014 Financial Results 28AbbVie Reports Second-Quarter 2014 Financial Results 29AbbVie Reports Second-Quarter 2014 Financial Results 30AbbVie Reports Second-Quarter 2014 Financial Results 31AbbVie Reports Second-Quarter 2014 Financial Results 32
... SEATTLE, March 25 Cell Therapeutics, Inc.,(CTI) (Nasdaq: ... complete in,the phase III EXTEND (PIX301) clinical trial of ... non-Hodgkin,s lymphoma (NHL).,An analysis of the data is expected ... with the U.S. Food and Drug Administration (FDA) the ...
... Patients to ... Higher Rates of BARACLUDE Resistance -, PRINCETON, N.J., ... a continued low incidence of,resistance in nucleoside-naive patients through ... patients analyzed, no additional,patient developed resistance in the fifth ...
Cached Medicine Technology:Cell Therapeutics, Inc. (CTI) Announces Enrollment Complete in Phase III EXTEND (PIX301) Clinical Trial of Pixantrone in Patients With Second or Greater Relapse of Diffuse Large B Cell NHL 2Cell Therapeutics, Inc. (CTI) Announces Enrollment Complete in Phase III EXTEND (PIX301) Clinical Trial of Pixantrone in Patients With Second or Greater Relapse of Diffuse Large B Cell NHL 3Cell Therapeutics, Inc. (CTI) Announces Enrollment Complete in Phase III EXTEND (PIX301) Clinical Trial of Pixantrone in Patients With Second or Greater Relapse of Diffuse Large B Cell NHL 4BARACLUDE(R) (entecavir) Data Continue to Demonstrate Low Incidence of Resistance Through Five Years of Treatment in Nucleoside-naive Chronic Hepatitis B Patients 2BARACLUDE(R) (entecavir) Data Continue to Demonstrate Low Incidence of Resistance Through Five Years of Treatment in Nucleoside-naive Chronic Hepatitis B Patients 3BARACLUDE(R) (entecavir) Data Continue to Demonstrate Low Incidence of Resistance Through Five Years of Treatment in Nucleoside-naive Chronic Hepatitis B Patients 4BARACLUDE(R) (entecavir) Data Continue to Demonstrate Low Incidence of Resistance Through Five Years of Treatment in Nucleoside-naive Chronic Hepatitis B Patients 5BARACLUDE(R) (entecavir) Data Continue to Demonstrate Low Incidence of Resistance Through Five Years of Treatment in Nucleoside-naive Chronic Hepatitis B Patients 6
(Date:7/26/2014)... European security and surveillance radar market under defense aviation ... is expected to reach $1800 million by 2019 at ... that influence a country’s expenditure on radars. It provides ... The report also throws light on the leading competitors ... of the companies, it focuses on their financial position, ...
(Date:7/26/2014)... Recently, iFitDress.com, a popular supplier of ... unveiled its new range of high quality party outfits. ... brand new items; they are now provided at discounted ... is one of the leading suppliers in the international ... wholesale party dresses have flattering looks and ...
(Date:7/26/2014)... 26, 2014 As reported by ... changing based on 3 factors: smaller spaces, multi-generational access, ... bathroom trend of 2014 lists, including this article ... Amerec , a leading manufacturer of steam bath ... largely due to smaller spaces and an effort to ...
(Date:7/26/2014)... July 26, 2014 “Healthy teeth are important, ... those pearly whites shining,” says Community Health Center of Snohomish ... ." , They believe that an integration of medical and ... and well. Because of this, they encourage regular cleanings and ... dentist . , “Children and adults will find ...
(Date:7/26/2014)... OH (PRWEB) July 26, 2014 The U.S. ... guidelines list that includes a new medication guide for AndroGel ... a serious side-effect of taking the topical low testosterone medication, ... that AbbVie Inc., the makers of the low testosterone theapy ... symptoms of pain, swelling or redness as signs of a ...
Breaking Medicine News(10 mins):Health News:Europe Security and Surveillance Radar Market is Expected to Reach $1800 million in 2019 - New Report by MicroMarket Monitor 2Health News:Europe Security and Surveillance Radar Market is Expected to Reach $1800 million in 2019 - New Report by MicroMarket Monitor 3Health News:Europe Security and Surveillance Radar Market is Expected to Reach $1800 million in 2019 - New Report by MicroMarket Monitor 4Health News:Europe Security and Surveillance Radar Market is Expected to Reach $1800 million in 2019 - New Report by MicroMarket Monitor 5Health News:High Quality Wholesale Party Dresses Online at iFitDress.com 2Health News:Amerec Finds Bathroom Design Trends Change Based on Water Consumption and Other Factors 2Health News:Common Dental Care Questions Answered by Community Health Center of Snohomish County in Recent Article 2Health News:FDA Updates AndroGel Risks to Include Blood Clots In Legs and Lungs as Testosterone Treatment Lawsuits Move Forward 2Health News:FDA Updates AndroGel Risks to Include Blood Clots In Legs and Lungs as Testosterone Treatment Lawsuits Move Forward 3Health News:FDA Updates AndroGel Risks to Include Blood Clots In Legs and Lungs as Testosterone Treatment Lawsuits Move Forward 4Health News:FDA Updates AndroGel Risks to Include Blood Clots In Legs and Lungs as Testosterone Treatment Lawsuits Move Forward 5
... , ORANGE COUNTY, Calif., Oct. 14 Beckman Coulter, Inc. ... conference call on Thursday, October 29, 2009, at 5:00 p.m. ... Earnings will be released after the market closes. , (Logo: ... by dialing (877) 516-3365 or (706) 679-3246 and asking for ...
... American Academy of Physician Assistants (AAPA), representing 75,000 ... States, applauds the Senate Finance Committee,s vote to ... is committed to seeking health care reform legislation ... quality, affordable, cost-effective health care. , "Physician ...
... Payment Would Cover Just Two Percent of Lost Income ... Security Administration is expected to announce that seniors will receive ... checks next year. , President Obama,s call late this ... for seniors would make up just a tiny fraction of ...
... Inc. magazine ranked Texas Physical Therapy Specialists ... an exclusive ranking of the nation,s fastest-growing private companies. The ... segment of the economy--America,s independent-minded entrepreneurs. , "If you want ... look at the Inc. 500," said Inc. editor Jane Berentson. ...
... received artificial kidney treatment: study , WEDNESDAY, Oct. 14 (HealthDay ... older Americans in nursing homes who suffer kidney failure in ... published in the Oct. 15 issue of the New ... to lengthen or improve most patients, lives. , "The hope ...
... ... and CEO of Atlanta-based Jackson Healthcare, proposed a radical plan to ... stage as the current administration spearheads an aggressive reform of the ... propaganda that have saturated the news, Jackson’s core argument remains as ...
Cached Medicine News:Health News:American Academy of Physician Assistants Applauds Senate Finance Committee for Advancing Health Reform Legislation 2Health News:Social Security COLA: Tomorrow's Zero COLA Announcement for 2010 Could Cost Average Senior $10,134 2Health News:Inc. Magazine Unveils 28th Annual List of America's Fastest-Growing Private Companies - the Inc. 500 2Health News:Dialysis' Drawbacks Outweigh Benefits for Some Older Patients 2Health News:Dialysis' Drawbacks Outweigh Benefits for Some Older Patients 3Health News:Restoring the Physician/Patient Relationship: An Interview with Jackson Healthcare's CEO 2Health News:Restoring the Physician/Patient Relationship: An Interview with Jackson Healthcare's CEO 3Health News:Restoring the Physician/Patient Relationship: An Interview with Jackson Healthcare's CEO 4Health News:Restoring the Physician/Patient Relationship: An Interview with Jackson Healthcare's CEO 5
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: